Quell Therapeutics Appoints Luke Devey, BMBCh, Ph.D. as Chief Medical Officer ...Middle East

Adds significant clinical, translational science and immunology expertise to leadership team as Quell prepares to advance QEL-001 into its first clinical trial and progresses its CAR-Treg cell therapy pipeline programs in Auto-Immunity and Neuro-Inflammation LONDON, Nov. 21, 2022...

Hence then, the article about quell therapeutics appoints luke devey bmbch ph d as chief medical officer was published today ( Monday 21/11/2022 - 12:12 PM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Quell Therapeutics Appoints Luke Devey, BMBCh, Ph.D. as Chief Medical Officer )

Also on site :

• 'Big Bang Theory' Actress Kaley Cuoco Drops a Hint About Possible Return
• Vera Bradley’s 'Roomy' Zip Tote Is on Sale for $30 and Perfect for Work, Travel, or Errands
• This Is Hands-Down the Best Drink for Gut Health, According to Gastroenterologists